2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma
Four Pivotal Trends Revolutionizing Market Access Strategies
2025 Pharma Forecast – Trends to Watch
As the pharmaceutical landscape evolves, ensuring market access should remain a top priority for industry stakeholders. As we look ahead to a year of expected advancements, several key trends will shape the landscape for manufacturers and key players. Archbow Consulting has detailed four prevalent topics highlighting the industry’s movement toward digital transformation, cost management, treatment innovation, and value-based service delivery.
Pharmaceutical Executive teamed with Archbow Consulting to help market access teams start thinking about how they can tell their story in the year ahead. These four trends detail why evolved preparation, thought, and engagement will be needed to meet transformative changes in 2025. We hope this list gives you the added insight to help you maximize your opportunities over the next year.
How did we do on this list? Is there anything else you would have included? Let us know – we’d love to hear from you.
For additional insights on this topic, you may also enjoy the following:
From Roadblocks to Runways: Aligning Services for a Smooth Patient Journey
Proven strategies for mapping and optimizing the patient journey, from diagnosis to ongoing care.
The Rise of Digital Health and Technology Integration in the Pharmaceutical Industry
In 2025, digital health is no longer a future consideration—it is a present imperative for key industry players in the pharmaceutical services sector, including manufacturers, specialty pharmacies, payers, and providers
Direct-to-Consumer (DTC) Changes Under the New Executive Order: What You Need to Know
As the US administration urges leading pharmaceutical manufacturers to implement MFN prescription drug pricing solutions, innovative approaches like DTC distribution for prescription medications are gaining increased attention.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|